Diabetic Ketoacidosis With SGLT2 Inhibitors Is ManageableDiabetic Ketoacidosis With SGLT2 Inhibitors Is Manageable

Two diabetes clinical trialists argue that SGLT2 inhibitors are still safe and effective despite the diabetic ketoacidosis risk, including in patients with type 1 diabetes. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news